European Union antitrust regulators are to put major financial services firms under the microscope by examining the impact of syndicated loans on credit markets.
“The fact that the (European) Commission commissions a study in a specific market does not in any way imply that there is anti-competitive behavior taking place or that the Commission would open an investigation into that market,” spokesman Ricardo Cardoso said in an email on Monday.
In Europe, bank loans traditionally accounted for around 70 percent of lending to companies and other borrowers. This contrasts with the United States where the credit markets have made up some 70-80 percent of where companies borrow.
The European Commission said its interest had been prompted by the growing importance of loan syndication, in which institutional investors and banks lend to a borrower for a fee.
Authorities around the world have taken a similarly tough line against rate-rigging and other infringements.
The study is expected to take nine months and will focus on six countries, according to a tender for the study issued by the EU executive, which did not name them.
“The study will examine the structure and process of loan syndication, also in light of recent regulatory reforms which aim to increase supervision and capital requirements,” Cardoso said.
Full Content: Mondaq
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas